(Total Views: 510)
Posted On: 07/19/2021 6:37:37 AM
Post# of 145890
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Breast cancer CURE for CCR5+ TNBC?? I’ll echo: “Amazing!!!”
Quote:
Daniel Adams, Director of Clinical Research & Development, Creatv MicroTech, Inc., stated, “While these are only interim results at the 12-month point, our ability to rapidly monitor and identify patients that appear to respond to leronlimab using a single tube of blood is quite an encouraging finding. The fact that greater than 70% of patients saw positive changes in circulating tumor cells after a single dose of leronlimab was made even more informative by their dramatic increases in both progression-free survival and overall survival. The fact that a large group of patients taking leronlimab had an mPFS of approximately 6 months is well beyond that experienced with current treatment options available to these women, who typically have mPFS of approximately 2 months. This result is even more amazing as these women did not even reach mOS in 12 months, considering the typical mOS in this population is only 6 to 7 months.”
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)